Advertisement

The Respiratory System

  • John C. Wright

Abstract

Not only is respiratory disease encountered in family practice with considerable frequency, but it can also represent a vast spectrum of severity ranging from such entities as self-limited acute bronchitis to devastating lung cancer or gram-negative pneumonia. In all circumstances, the family physician must approach the patient with the assumption of being the primary responsible physician. He/she is the one member of the medical establishment to whom this patient can consistently and easily relate, and from whom reassurance and alleviation of anxiety, or simply complete honest information, may be expected.

Keywords

Chronic Obstructive Pulmonary Disease Pulmonary Embolism Family Physician Force Vital Capacity Bacterial Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chusid EL: Diagnostic procedures in bronchopulmonary disease. Hosp Pract 16 (7): 99–108, 1981.Google Scholar
  2. 2.
    Goodman LR, Goren RA, Teplick SK: The radiographic evaluation of pulmonary infection. Med Clin North Am 64 (3): 553–574, 1980.PubMedGoogle Scholar
  3. 3.
    Boerner DF, Zwadyk P: The value of the sputum gram’s stain in community-acquired pneumonia. JAMA 247: 642–645, 1982.PubMedCrossRefGoogle Scholar
  4. 4.
    GuckianJG, Christensen WD: Quantitative culture and gram stain of sputum in pneumonia. Am Rev Respir Dis 118: 997–1005, 1978.Google Scholar
  5. 5.
    Bean SM, Kinderlehrer DA: Transtracheal aspiration: A useful technique for the family physician. Fam Pract Recert 3 (7): 62–72, 1981.Google Scholar
  6. 6.
    Good JT Jr, Taryle DA, Maulitz RM, Kaplin RL, Sahn SA: The diagnostic value of pleural fluid pH. Chest 78 (1): 55–59, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Sahn SA: Pleural manifestations of pulmonary disease. Hosp Pract 16 (3): 73–79, 1981.Google Scholar
  8. 8.
    Light RW, MacGregor I, Luchsinger PC, Ball WC Jr: Pleural effusions: The diagnostic separation of transudates and exudates. Ann Intern Med 77: 507–513, 1972.PubMedCrossRefGoogle Scholar
  9. 9.
    Hunder GG, McDuffie FC, Kent AH, Elveback LR, Hepper NG: Pleural fluid complement, complement conversion, and immune complexes. Immunologic and nonimmunologic diseases. 90: 971–980, 1977.Google Scholar
  10. 10.
    Petty TL, Lakshminarayan S: Practical pulmonary function tests. In: Petty TL (ed.) Pulmonary Diagnostic Techniques. Philadelphia, Lea & Febiger, 1975, pp. 1–50.Google Scholar
  11. 11.
    Younes MD, Reemers JE: Laboratory evaluation of respiratory disease. Cont Ed 6: 30–39, 1977.Google Scholar
  12. 12.
    Dosman JA, Cotton DJ: Interpretation of tests of early lung dysfunction. Chest 79 (3): 261–262, 1981.PubMedCrossRefGoogle Scholar
  13. 13.
    Altrose MD, Netter FH: The physiologic basis of pulmonary function testing. Clin Symp 31 (2): 1–39, 1979.Google Scholar
  14. 14.
    Burki NK: Spirometry and other pulmonary function tests. J Fam Pract 12 (1): 119–124, 1981.PubMedGoogle Scholar
  15. 15.
    Shapiro BA: Clinical Application of Blood Gases. Chicago, Yearbook Medical Publishers, 1973, p. 210.Google Scholar
  16. 16.
    Fink JN: Immunologic lung diseases. Hosp Pract 16 (5): 53–63, 1981.Google Scholar
  17. 17.
    Netter FH, Ziskind MM: Silicotuberculosis and rheumatoid pneumoconiosis. In: Netter FH (ed.) CIBA Collection of Medical Illustrations: Respiratory System. Summit, NJ, CIBA, 1979, p. 209.Google Scholar
  18. 18.
    Schatz M, Patterson R, Fink J: Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol 60 (1): 27–37, 1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Schatz M, Patterson R, Fink J: Immunologic lung disease. N Engl J Med 300 (23): 1310–1320, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 89 (part 1): 660–676, 1978.PubMedCrossRefGoogle Scholar
  21. 21.
    Daten JE, Alpert JS: Natural history of pulmonary embolism. In: Sasahara AA, Sonnenblick EH, Lesch M (eds.). Progress in Cardiovascular Diseases, Vol. 11. New York, Grune & Stratton, 1974–75, pp. 77–78.Google Scholar
  22. 22.
    Sheery S: Preventing pulmonary embolism with heparin in small doses. Postgrad Med 59: 80–84, 1976.Google Scholar
  23. 23.
    Rosenow EC III, Osmundson PJ, Brown ML: Pulmonary embolism. Mayo Clin Proc 56: 161–178, 1981.PubMedGoogle Scholar
  24. 24.
    Stein PD, Willis PW III, Demets DL: History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol 47: 218–223, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Clarke DB: Pulmonary embolectomy re-evaluated. Ann R Coll Surg Engl 63: 18–24, 1981.PubMedGoogle Scholar
  26. 26.
    Sharma GVRK, Sasahara AA: Diagnosis of pulmonary embolism in patients with chronic obstructive pulmonary disease. J Chronic Dis 28: 253–257, 1975.PubMedCrossRefGoogle Scholar
  27. 27.
    National Institutes of Health: Consensus Development Conference: Thrombolytic Therapy in Thrombosis. (summary). Ann Intern Med 93: 141–144, 1980.CrossRefGoogle Scholar
  28. 28.
    National Institutes of Health: Consensus Development Conference, Vol. 3: Thrombolytic therapy in thrombosis (summary). Stroke 12: 17–21, 1981.CrossRefGoogle Scholar
  29. 29.
    National Institutes of Health: Consensus Development Conference: Thrombolytic therapy in thrombosis (summary). Br Med J 280: 1585–1587, 1980.CrossRefGoogle Scholar
  30. 30.
    Kelly MJ, Elliott LP: The radiologic evaluation of the patient with suspected pulmonary thrombolic disease. Med Clin North Am 59: 3–36, 1975.Google Scholar
  31. 31.
    Wilson JE III: Pulmonary embolism (part 1). Clin Notes Respir Dis 19 (4): 3–12, 1981.PubMedGoogle Scholar
  32. 32.
    Stanley DC, Shao-Ru C, Tisnado J, Vines FS, Coyne SS: Pulmonary arteriography in patients with hilar or mediastinal masses and lung scans suggesting pulmonary embolism. South Med J 74: 960–967, 1981.PubMedCrossRefGoogle Scholar
  33. 33.
    Sauter RD, Myers WO, Wenzel FJ: Pulmonary embolectomy; review and current status. In: Sasahara AA, Sonnenblick EH, Lesch M (eds.) Pulmonary Emboli, a Progress in Cardiovascular Diseases, Vol. 17, Reprint. New York, Grune & Stratton, 1974–75, p. 143.Google Scholar
  34. 34.
    Marder VJ: The use of thrombolytic agents: Choice of patient, drug administration, laboratory monitoring. Ann Intern Med 90: 802–808, 1979.PubMedCrossRefGoogle Scholar
  35. 35.
    Genton E: Thrombolytic therapy of pulmonary embolism. Prog Cardiovasc Dis 21: 333–341, 1970.CrossRefGoogle Scholar
  36. 36.
    Bell WR, Meek AG: Guidelines for the use of thrombolytic agents. N Engl J Med 301: 1266–1270, 1979.PubMedCrossRefGoogle Scholar
  37. 37.
    Sharma GVRK, Burleson BS, Sasahara AA: Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolus. N Engl J Med 303: 842–845, 1980.PubMedCrossRefGoogle Scholar
  38. 38.
    Schrier ST, Sasahara AA, Wall RT, Harbury: The use of fibrinolytic agents. In: Stanford University School of Medicine (Specialty Conference). West J Med 134:128–133, 1981.Google Scholar
  39. 39.
    Genton I, Hirsh J: Observations in anticoagulant and thrombolytic therapy in pulmonary embolism. In: Sasahara AA, Sonneblick EH, Lesch M (eds.) Progress in Cardiovascular Diseases, Vol. X. New York, Grune & Stratton, 1975, pp. 107–115.Google Scholar
  40. 40.
    Wildon JE III: Pulmonary embolism diagnosis and treatment (part 2). Clin Notes Respir Dis 20: 3–11, 1981Google Scholar
  41. 41.
    Keogh BA, Crystal RG: Clinical significance of pulmonary function tests; Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest 78: 856–865, 1980.PubMedCrossRefGoogle Scholar
  42. 42.
    Teirsten AS, Kleinerman J: Diffuse interstitial lung disease. Hosp Pract 16 (6): 126–136, 1981.Google Scholar
  43. 43.
    Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: NIH conference: Idiopathic pulmonary fibrosis; clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 85: 769–788, 1976.PubMedCrossRefGoogle Scholar
  44. 44.
    Weinberger SE, Kelman JA, Elson NA, Young RC, Reynolds HY, Fulmer JD, Crystal RG: Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 89: 459–466, 1978.PubMedCrossRefGoogle Scholar
  45. 45.
    Netter FH, Teirstein AS, Churg J: Idiopathic diffuse interstitial pulmonary fibrosis (Hamman-Rich syndrome, cryptogenic fibrosing alveolitis). In Netter FH (ed.) The Ciba Collection of Medical Illustrations: Respiratory system. Summit, NJ, Ciba, 1979, pp. 253254.Google Scholar
  46. 46.
    Winterbauer RH, Hutchinson JF: Clinical significance of pulmonary function tests; use of pulmonary function tests in the management of sarcoidosis. Chest 78: 640–647, 1980.PubMedCrossRefGoogle Scholar
  47. 47.
    Crystal RG, Robarts WC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR: National Institutes of Health Conference: Pulmonary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 94: 73–94, 1981.CrossRefGoogle Scholar
  48. 48.
    Cumming G, Semple SJ: Disorders of the Respiratory System. Oxford, Blackwell Scientific Publications, 1973, p. 264.Google Scholar
  49. 49.
    Hoeprich PD: Infectious Disease. Hagerstown, MD, Harper & Row, 1972, p. 287.Google Scholar
  50. 50.
    Hirsch SR: The expectorant effects of glycerol guaiacolate in patients with chronic bronchitis. Chest 63: 914, 1973.CrossRefGoogle Scholar
  51. 51.
    Wong GA: Penetration of antimicrobial agents into bronchial secretions. Am J Med 59: 219–223, 1975.PubMedCrossRefGoogle Scholar
  52. 52.
    Nelson WE, Vaugh VC, McKay RJ: Textbook of Pediatrics, 9th ed. Philadelphia, Saunders, 1969, p. 913.Google Scholar
  53. 53.
    Simpson H, Matthew DJ, Habel AH, George EF: Acute respiratory failure in bronchiolitis and pneumonia in infancy: Modes of presentation and treatment. Br Med J 2: 632–636, 1974.PubMedCrossRefGoogle Scholar
  54. 54.
    Harris S: Influenza. Baltimore, Williams & Wilkins, 1965, p. 8.Google Scholar
  55. 55.
    Delker LL, Moser RH, Nelson JD, Rodstein M, Rolls K, Sanford JP, Swartz MN: Amantadine: Does it have a role in the prevention and treatment of influenza? A National Institutes of Health Concensus Development Conference. Ann Intern Med 92 (part 1): 256–258, 1980.Google Scholar
  56. 56.
    Douglas RG: Treatment of influenza. Res Staff Physician 27 (12): 30–40, 1981.Google Scholar
  57. 57.
    Barker WH, Mullooly JP: Pneumonia and influenza deaths during epidemics; implications for prevention. Arch Intern Med 142: 85–89, 1982.PubMedCrossRefGoogle Scholar
  58. 58.
    Green FM, Jakab GJ, Low RB, Davis GS: State of the art: Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 115: 479–514, 1977.PubMedGoogle Scholar
  59. 59.
    Camner P: Clearance of particles from the human tracheobronchial tree. Clin Sci 59: 79–84, 1980.PubMedGoogle Scholar
  60. 60.
    Handbook of Antimicrobial Therapy. Abramowicz M (ed.) New Rochelle, New York, The Medical Letter, 1980, pp. 1–72.Google Scholar
  61. 61.
    McHenry MC: The infectious pneumonias. Hosp Pract 15 (12): 41–52, 1980.PubMedGoogle Scholar
  62. 62.
    Lerner MA: The classical bacterial pneumonias. DM 21 (2): 1–46, 1975.Google Scholar
  63. 63.
    Center for Disease Control: Legionnaire’s disease: Diagnosis and management. Ann Intern Med 88: 363365, 1978.Google Scholar
  64. 64.
    Shands KN, Fraser DW: Legionnaires’ disease. DM 26 (4): 1–40, 1980.Google Scholar
  65. 65.
    Meyer RD, Finegold SM: Legionnaires’ disease. Annu Rev Med 31: 219–232, 1980.PubMedCrossRefGoogle Scholar
  66. 66.
    Evans AF, Oakley RH, Whitehouse GH: Analysis of the chest radiograph in Legionnaires’ disease. Clin Radiol 32: 361–365, 1981.PubMedCrossRefGoogle Scholar
  67. 67.
    Brown RB, Landis JN: Update on non hospital-acquired pneumonias. Primary Care 6 (3): 463–481, 1979.PubMedGoogle Scholar
  68. 68.
    Reyes MP: The aerobic gram-negative bacillary pneumonias. Med Clin North Am 64 (3): 363–383, 1980.PubMedGoogle Scholar
  69. 69.
    Wallace RJ, Musher DM, Martin RR: Hemophilus influenzae pneumonia in adults. Am J Med 68: 87–93, 1978.CrossRefGoogle Scholar
  70. 70.
    Levin DC, Schwarz MI, Matthey RA, LaForce FM: Bacteremic Hemophilus influenza pneumonia in adults. Am J Med 62: 219–224, 1977.PubMedCrossRefGoogle Scholar
  71. 71.
    Rahman M: Quality of specimens and sputum culture results: A retrospective study. Postgrad Med J 55: 553555, 1979.Google Scholar
  72. 72.
    Kohler RB, Zimmerman SE, Wilson E, Allen SD, Edelstein PH, Wheat LJ, White A: Rapid radioimmunoassay diagnosis of Legionnaries’ disease: Detection and partial characterization of urinary antigen. Ann Intern Med 94: 601–605, 1981.PubMedCrossRefGoogle Scholar
  73. 73.
    Pneumococcal polysaccharide vaccine. MMWR 30(33): 410–411, 417–419, 1981.Google Scholar
  74. 74.
    Hirschmann JV, Lipsky BA: Pneumococcal vaccination in the United States: A critical analysis. JAMA 246: 1428–1432, 1981.PubMedCrossRefGoogle Scholar
  75. 75.
    Netter FH, Weiss W: Lung Abscess. In: Netter FH (ed.) The Ciba Collection of Medical Illustrations. Summit NJ, Ciba, 1979, pp. 188–189.Google Scholar
  76. 76.
    Gopalakrishna KV, Lerner PI: Primary lung abscess: Analysis of 66 cases. Cleve Clin Q 42: 3–13, 1975.PubMedGoogle Scholar
  77. 77.
    Irwin RS, Garrity FL, Erickson AD, Corrao WM, Kaemmerlen JT: Sampling lower respiratory tract secretions in primary lung abscess: A comparison of the accuracy of four methods. Chest 79: 559–565, 1981.PubMedCrossRefGoogle Scholar
  78. 78.
    Stevens DA: Viral and mycoplasma pneumonias. Postgrad Med 552: 81–86, 1974.Google Scholar
  79. 79.
    Levine KP, Lerner AM: The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am 62: 961–978, 1978.PubMedGoogle Scholar
  80. 80.
    Sbarbaro JA: Tuberculosis. Med Clin North Am 64: 417–431, 1980.Google Scholar
  81. 81.
    Diagnostic standards and classification of tuberculosis and other mycobacterial diseases. New York American Lung Association, 1974, p. 10.Google Scholar
  82. 82.
    The Scientific Assembly on Tuberculosis and the Tuberculosis Control Division of CDC. Guidelines for short-course tuberculosis chemotherapy. MMWR 29: 97–100, 105, 1980.Google Scholar
  83. 83.
    Followup on guidelines for short-course tuberculosis therapy. MMWR 29: 183–185, 1980.Google Scholar
  84. 84.
    Goodwin RA, DesPrez RM: Histoplasmosis. Am Rev Respir Dis 117: 929–956, 1978.Google Scholar
  85. 85.
    Drutz DJ, Catanzaro A: Coccidiomycosis. Part I. Am Rev Respir Dis 117: 559–585, 1978.PubMedGoogle Scholar
  86. 86.
    Drutz et al.: Coccidiomycosis. Part II. Am Rev Respir Dis 117: 727–771, 1978.Google Scholar
  87. 87.
    Duperval R, Hermans PE, Brewer NS, Roberts GD: Cryptococcus, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest 72: 13–19, 1977.PubMedCrossRefGoogle Scholar
  88. 88.
    Fanta CH, Pennington JE: Fever and new lung infiltrates in the immunocompromised host. Clin Chest Med 2: 19–39, 1981.PubMedGoogle Scholar
  89. 89.
    Carbone PP, Fronst JK, Feinstein AR: Lung cancer: Perspectives and prospects. Ann Intern Med 73: 1003 1004, 1970.Google Scholar
  90. 90.
    Carr DT: Diagnosis and staging In: Handen HH, Roth M (eds.). Lung Cancer 1980: Second World Conference on Lung Cancer, Copenhagen, June 1980. New York, Excerpta Medica, 1981, pp. 49–71.Google Scholar
  91. 91.
    Heitzman ER, Markarian B, Soloman J: Chronic obstructive pulmonary disease. Radiol Clin North Am 11: 49–75, 1973.PubMedGoogle Scholar
  92. 92.
    Miller WF: Chronic obstructive pulmonary disease. Hosp Pract 17 (10): 89–106, 1982.Google Scholar
  93. 93.
    Reynolds HY, Merrill WW: Airway changes in young smokers that may ante-date chronic obstructive lung disease. Med Clin North Am 65: 667–689, 1981.PubMedGoogle Scholar
  94. 94.
    Morris JF, Edwards MJ, Hass H, Hall C, Niles NR, Ritzman LW, Tuhy JE (COPD manual committee of the Oregon Thoracic Society): Chronic obstructive pulmonary disease. New York, American Lung Association, 1977.Google Scholar
  95. 95.
    Hudson LD, Pierson DJ: Comprehensive respiratory care for patients with chronic obstructive pulmonary disease. Med Clin North Am 65: 629–645, 1981.PubMedGoogle Scholar
  96. 96.
    Lieberman J: Elastase, collagenase, emphysema, and alphai-antitrypsin deficiency. Chest 70: 62–67, 1976.PubMedCrossRefGoogle Scholar
  97. 97.
    Alexander MR, Dull WL, Kasik JE: Treatment on chronic obstructive pulmonary diseases with orally administered theophylline: A double-blind, controlled study. JAMA 224: 2286–2290, 1980.CrossRefGoogle Scholar
  98. 98.
    Hodgen JE, Balchum OJ, Kass I, Glaser EM, Miller WF, Haas A, Shaw DB, Kimbel P, Petty TL: Chronic obstructive airway disease. JAMA 232: 1243–1260, 1975.CrossRefGoogle Scholar
  99. 99.
    Putnam JS, Beechler CR: Comprehensive care in chronic obstructing pulmonary disease. Primary Care 3: 593–608, 1976.PubMedGoogle Scholar
  100. 100.
    Richardson PS: The principles of drug action on cough and on sputum characteristics. EurJ Respir Dis (Suppl) 61 (110): 67–79, 1980.Google Scholar
  101. 101.
    Zanzanian MH: Expectorants and antitussive agents: Are they helpful? Ann Allergy 44: 290–295, 1980.Google Scholar
  102. 102.
    Pennington JE: Penetration of antibiotics into respiratory secretions. Rev Infect Dis X (1): 67–40, 1981.CrossRefGoogle Scholar
  103. 103.
    Fouts JB, Brashear RE: Intermittant positive pressure breathing. Postgrad Med 59: 103–107, 1976.PubMedGoogle Scholar
  104. 104.
    Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive long disease. Ann Intern Med 93: 391–398, 1980.CrossRefGoogle Scholar
  105. 105.
    Petty TL: Home oxygen therapy for COPD: Practical aspects. Postgrad Med 69 (4): 102–118, 1981.PubMedGoogle Scholar
  106. 106.
    Petty TL: Home oxygen in advanced chronic obstructive pulmonary disease. Med Clin North Am 65: 615627, 1981.Google Scholar
  107. 107.
    Timms RM, Kvale PA, Anthonisen NR, Boylen CT, Cugell DW, Petty TL, Williams FW: Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. JAMA 245: 2514–2515, 1981.PubMedCrossRefGoogle Scholar
  108. 108.
    Learley R, Wynne JW, Block AJ, Boylen PG, Lindsey, Martin C: The effect of low flow oxygen on sleep-disordered breathing and oxygen desaturation; a study of patients with chronic obstructive lung disease. Chest 78: 682–685, 1980.CrossRefGoogle Scholar
  109. 109.
    Roberts SD: Cost effective oxygen therapy. Ann Intern Med 93: 499–500, 1980.PubMedCrossRefGoogle Scholar
  110. 110.
    Brown HV, Wasserman K: Exercise performance in chronic obstructive pulmonary diseases. Med Clin North Am 65: 525–547, 1981.PubMedGoogle Scholar
  111. 111.
    Alison JA, Smaios R, Anderson SD: Evaluation of exercise training in patients with chronic airway obstruction. Phys Ther 61: 1273–1277, 1981.PubMedGoogle Scholar
  112. 112.
    Windsor RA, Green LW, Roseman JM: Health promotion and maintenance for patients with chronic •obstructive pulmonary disease: A review. J Chronic Dis 33: 5–12, 1980.PubMedCrossRefGoogle Scholar
  113. 113.
    Matts SG, Flavell: Acute bronchitis, chronic bronchitis, and bronchiectasis. Br J Clin Pract 27: 9–12, 1973.PubMedGoogle Scholar
  114. 114.
    Ziskind M, Jone RN, Weill H: Silicosis. Am Rev Respir Dis 113: 643–665, 1976.Google Scholar
  115. 115.
    Backlake MR: Asbestosis-related diseases of the lung and other organs: Their epidemiology and implications for clinical practice. Am Rev Respir Dis 114:187— 227, 1976.Google Scholar
  116. 116.
    Morgan WKC: Coal workers pneumoconiosis. In Morgan WKC, Seaton A (eds.) Occupational Lung Diseases. Philadelphia, Saunders, 1975, pp. 149–215.Google Scholar
  117. 117.
    Boehlecke BA, Merchant JA: The use of pulmonary function testing and questionnaires as epidemiologic tools in the study of occupational lung disease. Chest (Suppl) 79 (4): 1145–1225, 1981.Google Scholar
  118. 118.
    Weill H: Occupational Lung diseases. Hosp Pract 16 (4): 65–80, 1981.Google Scholar
  119. 119.
    Ahluwalia MP, MacDonnell: Pleural effusions. Comp Ther 7: 6–13, 1981.Google Scholar
  120. 120.
    Varkey B, Rose HD, Kesavan K, Politis J: Empyema thoracis during a ten-year period; Arch Intern Med 141: 1771–1776, 1981.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • John C. Wright

There are no affiliations available

Personalised recommendations